These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8658748)

  • 1. Hyperamylasemia in kidney transplant recipients.
    Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney transplantation at one center: 1-year results.
    Haberal M; Bilgin N; Karakayali H; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E
    Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplantation in Singapore.
    Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
    Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 6. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.
    Gracida C; Melchor JL
    Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318
    [No Abstract]   [Full Text] [Related]  

  • 8. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract]   [Full Text] [Related]  

  • 9. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine.
    Isa WA; Robles JE; Rosell D; Aguera LG; de Castro F; Sanchez PL; Zudaire JJ; Errasti P; Berian JM
    Transplant Proc; 1992 Feb; 24(1):115-7. PubMed ID: 1539200
    [No Abstract]   [Full Text] [Related]  

  • 10. Chagas disease and transplantation.
    Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
    Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of corbrin capsule in human renal transplantation.
    Min Z; Oi J; Zhu Y; Wei W
    Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
    [No Abstract]   [Full Text] [Related]  

  • 12. Tubular effects of cyclosporine in pediatric renal transplant recipients.
    Laine J; Holmberg C
    Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of immunosuppression at the University of Minnesota.
    Matas AJ; Sutherland DE; Najarian JS
    Transplant Proc; 2004 Mar; 36(2 Suppl):64S-70S. PubMed ID: 15041309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1714-5. PubMed ID: 11119904
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
    Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
    Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
    [No Abstract]   [Full Text] [Related]  

  • 16. Obese kidney transplant recipients have good outcomes.
    Howard RJ; Thai VB; Patton PR; Hemming AW; Reed AI; Van der Werf WJ; Fujita S; Karlix JL; Scornik JC
    Transplant Proc; 2001; 33(7-8):3420-1. PubMed ID: 11750464
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplant from live donors over 65 years old.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):2139-40. PubMed ID: 8066699
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapeutic window of cyclosporine in Chinese recipients of renal transplantation.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1995 Feb; 27(1):850-1. PubMed ID: 7879203
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life after cadaveric renal transplantation from a non-heart-beating donor.
    Shimada H; Sakamoto K; Hori S; Asano T; Suzuki T; Gunji Y; Nakajima K; Kenmochi T; Hayashi H; Takeda A; Arita S; Kashiwabara H; Yokoyama T; Ochiai T
    Transplant Proc; 2000 Nov; 32(7):1606-7. PubMed ID: 11119857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.